Podcasts about Biomarker

Thinking Thoracic host Dr. Erin Gillaspie and Dr. Stephen Liu,  associate professor of medicine at Georgetown University and head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, discuss the surgeon's role in navigating the biomarker space and working collaboratively with oncology colleagues.  

Die Diagnose Brustkrebs trifft jedes Jahr zehntausende Frauen wie ein Schock. Mehr als 70.000 Neuerkrankungen werden jährlich in Deutschland registriert; es handelt sich damit um die häufigste Krebsform bei Frauen und insgesamt die dritthäufigste Art von Krebs. Es gibt jedoch eine Vielzahl von Behandlungsmöglichkeiten, die im Idealfall möglichst individuell auf die einzelne Patientin zugeschnitten sind.

Zum YouTube Video und YouTube Kanal gleich abonnieren und keine neue Folge mehr verpassenZusammenfassungIst die Angst vor gesättigten Fettsäuren und Milchfett überholt?

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VRB865. CME/MOC/AAPA credit will be available until March 17, 2026.Integrating Biomarker Testing Into Alzheimer's Disease Workflows: Tools and Strategies for Specialty Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Helena Yu, MD and Joshua Sabari, MD explore the importance of testing for HER2 alterations in lung cancer; how HER2 positivity influences clinical decision-making; and the key methods used for detection, including immunohistochemistry, fluorescence in situ hybridization, and next-generation sequencing. It also addresses challenges in standardizing HER2 testing, disparities in access to biomarker testing, and the evolving role of liquid biopsy compared to traditional tissue biopsy.

For this episode we are joined by EBM guru, Dr. Brian Locke, who deftly breaks down all of our statistics questions. Is half dose DOAC as good as full dose DOAC for preventing VTE, and does it reduce bleeding risk? Can procalcitonin reduce duration of antibiotics for infections without compromising mortality rates? Can LLMs like GPT-4 help physicians manage patients better? Can reinforcement learning models predict when to start vasopressin in patients with septic shock? What is the risk of resuming anticoagulation in patients with atrial fibrillation and prior intracerebral hemorrhage? Is high flow nasal cannula as good as non-invasive ventilation for different types of respiratory failure? We answer all these questions and more!Half Dose DOAC for Long Term VTE Prevention (RENOVE)Biomarker-Guided Antibiotic Duration (ADAPT-Sepsis)GPT-4 Assistance for Physician PerformanceOptimal Vasopressin Initiation for Septic Shock (OVISS)DOACs for A fib after ICH (PRESTIGE-AF)High Flow Nasal Cannula vs NIV for Respiratory Failure (RENOVATE)Music from Uppbeat (free for Creators!): https://uppbeat.io/t/soundroll/dope License code: NP8HLP5WKGKXFW2R

Prof. Sarah Camargos interviews Prof. Sun Ju Chung about his recent paper in the Movement Disorders Journal investigating diagnostic and prognostic capabilities of measuring blood mitochondrial DNA copy number (mtDNA-CN) for Parkinson's disease. Journal CME is available until March 3, 2026 Read the article.

How early can we find out if a pregnant woman is at risk for preeclampsia, and what can we do to mitigate that risk? Credit available for this activity expires: 3/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/preeclampsia-biomarker-screening-every-trimester-2025a100065r?ecd=bdc_podcast_libsyn_mscpedu

Join me for a fascinating conversation around an exciting breakthrough in dementia detection that's offering real hope for early intervention. Dr. Hans Frykman, Chief Scientific Officer at Neurocode Laboratories, is here to share groundbreaking insights into cutting-edge biomarkers that can identify pathology associated with Alzheimer's disease before symptoms even appear. What's even more fascinating is how these same tools are revealing neuroinflammation caused by infections, including COVID, Lyme disease, and mold exposure—issues that are incredibly relevant in functional medicine today. The assays Dr. Frykman and his team have developed, and continue to research, are transforming the way we think about diagnosing and addressing neurodegeneration. We're talking about a potential game-changer that allows us to intervene earlier, reverse damage, and ultimately improve the trajectory of these conditions. This is an extraordinary time in science and medicine, and the work we're discussing today is at the forefront of it all. Don't miss out on how this could reshape your practice. ~DrKF Check out the show notes at https://tinyurl.com/2t55s3y3 for the full list of links and resources. GUEST DETAILS Dr. Hans Frykman, MD PhD FRCPC hfrykman@neurocode.com Hans Frykman MD, Ph.D., FRCPC is the founder, CEO, and medical director of BC Neuroimmunology Lab located in the UBC hospital on the University of BC campus in Vancouver BC. He is the medical director for Lykke Lab a genetics laboratory also on the University of BC campus. Also, he is the CSO for Neurocode Lab Inc. in Bellingham WA, a high-complexity, specialty lab focused on neuroimmunology and biomarkers in neurodegeneration. Dr. Frykman has a clinical faculty position at the University of British Columbia, Faculty of Medicine, Division of Neurology. THANK YOU TO OUR SPONSORS DIAMOND DUTCH: https://dutchtest.com/for-providers Biotics Research: https://www.bioticsresearch.com/ GOLD TimeLine Nutrition: https://tinyurl.com/bdzx2xms Vibrant Wellness: https://www.vibrant-wellness.com/ EXCLUSIVE OFFERS FROM OUR SPONSORS OneSkin: Get 15% off OneSkin with the code DRKARA at oneskin.co/DRKARA Try Qualia NAD+ for up to 50% off! Visit http://qualialife.com/kara15 and use code KARA15 at checkout for an additional 15% off your entire purchase! Why MitoQ's mitochondria-targeting is a critical step for your healthspan and longevity strategy. https://tinyurl.com/2b5benmd Want more? CONNECT WITH DrKF Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Full article: White Matter Hyperintensities on High-Resolution 3-T MRI: Frequency in Mild Traumatic Brain Injury and Associations with Clinical Markers—A Prospective Controlled Multicenter Study Pranjal Rai, MBBS, discusses the AJR article by Tanwar et al., reporting a prospective multicenter study evaluating the potential role of white matter hyperintensities as a biomarker of mild traumatic brain injury.

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment - Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing - The Relationship Between Biomarker Testing & Precision Medicine - Types of Biomarker Tests for Cancer Treatment - Do I Need Biomarker Testing for My Cancer? - How is Biomarker Testing Done? Using Samples of Your Cancer & Your Healthy Cells - Samples are Sent to the Lab Where Pathologists Test for Certain Biomarkers - Some Results Might Lead to Genetic Testing – Inherited or Germline Mutations - Some Biomarker Testing is Done as Part of Clinical Trials for New Cancer Treatments - Other Uses of Biomarkers – Determining a Person's Cancer Risk or Finding Cancer - Biomarkers Used to Show if a Treatment is Effective or May Show if Cancer is Returning - Biomarkers Play Such an Important Role in Choosing the Best Treatment for You & In Determining Your Progress - Questions for Our Panel of Experts

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KRC865. CME credit will be available until February 26, 2026.Modern Practice Principles in Lung Cancer—First Find the Targets, Then Treat With Precision: A Concise Guide for Biomarker Testing and EGFR-Targeted Therapy in NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Both are Johnson & Johnson companies.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KRC865. CME credit will be available until February 26, 2026.Modern Practice Principles in Lung Cancer—First Find the Targets, Then Treat With Precision: A Concise Guide for Biomarker Testing and EGFR-Targeted Therapy in NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Both are Johnson & Johnson companies.Disclosure information is available at the beginning of the video presentation.

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KRC865. CME credit will be available until February 26, 2026.Modern Practice Principles in Lung Cancer—First Find the Targets, Then Treat With Precision: A Concise Guide for Biomarker Testing and EGFR-Targeted Therapy in NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Both are Johnson & Johnson companies.Disclosure information is available at the beginning of the video presentation.

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KRC865. CME credit will be available until February 26, 2026.Modern Practice Principles in Lung Cancer—First Find the Targets, Then Treat With Precision: A Concise Guide for Biomarker Testing and EGFR-Targeted Therapy in NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Both are Johnson & Johnson companies.Disclosure information is available at the beginning of the video presentation.

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

- Overview & Definition of Biomarkers - What are Some Examples of Biomarker Testing - How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer is so Important - The Role of the Pathologist - Benefits of Biomarker Testing & Precision Medicine - Predicting Response to Treatment - Clinical Trials: How Research Contributes to Your Treatment Options - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts

Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami.  Here he discusses the recent publication “Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis”.

Today as a bonus Adrienne is sharing a recent episode from her other show Modern Wellness Podcast.Sammi, Adrienne, and Oli, start by discussing the ever booming weight-loss drug market, citing sifted's article London startup raises $410m in one of Europe's biggest ever Series A rounds as it joins weight loss drugs frenzy.There's a discussion of the news that WHOOP have unlocked a new women's health biomarker using their user's data - but what can we learn from it? WHOOP Unlocks New Women's Health BiomarkerPlus Adrienne has a Modern Wellness Recommends that will keep us all happier in these cold winter months! Hosted on Acast. See acast.com/privacy for more information.

Episode 184: Multiple Myeloma BasicsSub-Interns and future Drs. Di Tran and Jessica Avila explain the symptoms, work up and treatment of multiple myeloma. Written by Di Tran, MSIV, Ross University School of Medicine; Xiyuan Yang, MSIV, American University of the Caribbean. Comments by Jessica Avila, MSIV, American University of the Caribbean. Edits by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Di: Hi everyone, this is Di Tran, 4th year medical student from Ross university.  It's a pleasure to be back.  To be honest, this project is a part of teamwork of two medical students, myself and another 4th year, her name is XiYuan.  She came from the AUC. Unfortunately, due to personal matters she was unable to make it to the recording today which makes me feel really sad. Jessica: My name is Jessica Avila, MSIV, American University of the Caribbean.Di: The topic we will present today is Multiple Myeloma. Multiple myeloma is typically a rare disease and it's actually a type of blood cancer that affects plasma cells in the bone marrow.Jessica: Let's start with a case: A 66-year-old male comes to his family doctor for an annual health checkup. He is not in any acute distress but he reports that he has been feeling tired and weaker than usual for the last 3 months. He also noticed that he tends to bruise easily. He has a history of arthritis and chronic joint pain, but he thinks his back pain has gotten worse in the last couple of months. Upon checking his lab values, his family doctor found that he has a calcium level of 10.8 and a creatinine level of 1.2, which has increased from his baseline. Given all that information, what do you think his family doctor is suspecting? And what kind of tests she can order for further evaluation?Di: Those symptoms sound awfully familiar – are we talking about the CRAB? You know, the diagnostic criteria for Multiple Myeloma.Jessica: Exactly! Those are called “myeloma-defining events.” Do you remember what those are?Di: CRAB criteria comes in 4 flavors.  It's HYPERCALCEMIA with >1mg/dL, RENAL INSUFFICIENCY with serum creatinine >2mg/dL, ANEMIA with hemoglobin value 10% plasma cells, PLUS any one or more of the CRAB features, we can make the official diagnosis of multiple myeloma. Di:  Before we go deeper, let's back up a little bit and do a little background.  So, what do we know about the immunoglobulins, also known as antibodies? Back from years of studying from medical school, we know that the plasma cells are the ones that producing the antibodies that help fight infections.  There  are various kinds that come with various functions.  Each antibody is made up of 2 heavy chains and 2 light chains.  For heavy chains, we have A, D, E, G, M and for light chains we have Kappa and Lambda.Jessica: Usually, the 5 possible types of immunoglobulins for heavy chains would be written as IgG, IgA, IgD, IgE, and IgM.  And the most common type in the bloodstream is nonetheless the IgG. Di: What is multiple myeloma? In myeloma, all the abnormal plasma cells make the same type of antibody, the monoclonal antibody.  The cause of myeloma is unknown, but there are lots of studies and evidence that show a number of potential etiologies, including viral, genetic, and exposure to toxic chemicals, especially the Agent Orange, which is a chemical used as herbicide and defoliant. It was used as a chemical warfare by the U.S. military during the Vietnam War from 1961 to 1971.Jessica: We need to order some specific blood tests to see if there is elevated monoclonal proteins in the blood or urine. So, to begin with we'll need to take a very thorough history and physical exam. Next, we'll do labs, such as CBC, basic metabolic panel, calcium, serum beta-2 microglobulin, LDH, total protein, and some not so common tests: serum protein electrophoresis (SPEP), immunofixation of blood or urine (IFE), quantitative immunoglobulins (QIg), serum free light chain assay, and serum heavy/light chain ratio assay.If any of the results is abnormal, we should consider referring our patient to an oncologist.Di: Interesting! I read that Multiple Myeloma symptoms vary in different patients.  In fact, about 10-20% of patients with newly diagnosed myeloma do not have any symptoms at all.   Otherwise, classic symptomatic presentations are weakness, fatigue, increased bruising under the skin, reduced urine output, weakened bones that is likely prone to fractures, etc. And if multiple myeloma is highly suspected, a Bone Marrow biopsy should be done with testing for flow cytometry and fluorescent in situ hybridization (FISH). Actually, if any of the “Biomarkers of malignancy (SLIM)” is met we can also diagnose multiple myeloma even without the CRAB criteria. Jessica: The diagnosis is made if one or more of the following is found: >= 60% of clonal plasma cells on bone marrow biopsy, > 1 lytic bone lesion on MRI that is at least 5mm in size, or a biopsy confirmed plasmacytoma. Di: Imaging comes in at the final step especially if we able to find one or more sites of osteolytic bone destruction > 5mm on an MRI scan.Jessica: What if the bone marrow biopsy returns > 10% of monoclonal plasma cells, but our patient doesn't have either the CRAB or the Biomarker criteria? Di: That's actually a very good question, since Multiple Myeloma is part of a spectrum of plasma cell disorders. That's when smoldering myeloma comes into play. It is a precursor of active multiple myeloma. Smoldering myeloma is further categorized as high-risk or low-risk based on specific criteria.A less severe form is called Monoclonal Gammopathy of Undetermined Significance, or simply MGUS, with < 10% bone marrow involvement. Those are diagnoses we give once we rule out actual multiple myeloma, which are defined by the amount of M-protein in the serum.Jessica:  When to get started on treatment? Multiple Myeloma is on a spectrum of plasma cells proliferative disorders, starting from MGUS to Smoldering Myeloma, to Multiple Myeloma and to  Plasma Cell Leukemia.  Close supervision/active watching is enough for MGUS and low risk Smoldering Myeloma. But once it has progressed to high-risk smoldering myeloma or to active Multiple Myeloma, chemotherapy is usually required. Some situations may require emergent treatment to improve renal function, reduce hypercalcemia, and to prevent potential infections.Di: As of 2024, treatment of Multiple Myeloma comprises the Standard-of-Care approved by the FDA. In fact, the quadruple therapy is a combination of 4 different class of drugs that include a monoclonal antibody, a proteasome inhibitor, an immunomodulatory drug, and a steroid. Jessica: They are Darzalex (daratumumab), Velcade (bortezomib), Revlimid (lenalidomide) and dexamethasone.  Other treatment plans for Multiple Myeloma include chemotherapy, immunotherapy, radiation therapy (for plasmacytomas) and stem cell transplants. The patient will also be on prophylaxis acyclovir and Bactrim while on chemotherapy. Sometimes anticoagulants are also considered because the chemo increases the risk of venous thromboembolic events.Di: Although the disease is incurable, but with the advancing of novel therapies and clinical trials patients with multiple myeloma are able to live longer.  Problem is the majority of patients diagnosed with Multiple Myeloma are older adults (>65), the risk of falling is adding to multiple complications of the disease itself, such as bone density loss, pain, neurological compromises, distress and weakness.  Palliative care may come in help at any point in time throughout the course of treatment but is most often needed at the very end of the course. Jessica, can you give us a conclusion for this episode?Jessica: Multiple Myeloma may not be the most common cancer, but we have to be aware of the symptoms and keep it in our differential diagnosis for patients with bone pain, easy bruising, persistent severe headaches, unexplained renal dysfunction, and remember the CRAB: HyperCalcemia, Renal impairment, Anemia and Bone lesions.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:International Myeloma Foundation. (n.d.). International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. https://www.myeloma.org/international-myeloma-working-group-imwg-criteria-diagnosis-multiple-myeloma Laubach, J. P. (2024, August 28). Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics). UpToDate. https://www.uptodate.com/contents/multiple-myeloma-symptoms-diagnosis-and-staging-beyond-the-basics.University of California San Francisco. (n.d.). About multiple myeloma. UCSF Helen Diller Family Comprehensive Cancer Center. https://cancer.ucsf.edu/research/multiple-myeloma/about Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Bill Campbell, PhD, has spent his entire career as a fat loss researcher. So when his wife hit menopause and wanted help with body composition changes, he thought it would be easy. Spoiler alert: It was not. Which made him realize his field had a lot to learn, especially about active women whose bodies change even when their training and nutrition has not. Now he's on a mission, diving into the literature and conducting research of his own to further our understanding of body composition changes during this time of life. We talk all about it, what he's learned, and his work developing a Female Fitness Menopause Survey to learn more.Bill Campbell, PhD is a Professor of Exercise Science and Director of the Performance and Physique Enhancement Laboratory at the University of South Florida. He is also a Certified Strength & Conditioning Specialist from the National Strength & Conditioning Association and former president of the International Society of Sports Nutrition (where he is also 1 of 35 individuals to be recognized as a ‘Fellow' of the organization—an honor reserved for those individuals who have outstanding contributions to the field of sports nutrition). He has published over 200 scientific papers and abstracts, three textbooks, and 20 book chapters in areas related to physique enhancement, sports nutrition, resistance training, and dietary supplementation. You can learn more about him and his work at www.billcampbellphd.comResourcesEstrogen modulates metabolic risk profile after resistance training in early postmenopausal women: a randomized controlled trial, hereTransdermal Estrogen Therapy Improves Gains in Skeletal Muscle Mass After 12 Weeks of Resistance Training in Early Postmenopausal Women, hereMetabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism, herePowerpenia Should be Considered a Biomarker of Healthy Aging, hereJoin the Feisty Girona Gravel Camp: https://www.thomsonbiketours.com/trips/feisty-girona-gravel-camp/ Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/ Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get $125 off Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Podcorn - https://podcorn.com/privacyPodscribe - https://podscribe.com/privacy